Executive Summary: The 55-to-64 Cohort: Senior Entrepreneurs in the Pre-Medicare Coverage Desert
LFP-06.02 — The Populations#
The decade between age 55 and Medicare eligibility at 65 is the most expensive coverage period in the working years and the least adequately served by existing product categories. This is not a market access failure. It is a product design failure, and the 55-to-64 cohort has the purchasing power to support a solution that does not yet exist.
Business formation in this age group has trended older for three decades. The Kauffman Foundation’s analysis of the Current Population Survey found that those aged 55 to 64 represented 14.8% of new entrepreneurs in 1996 and approximately 25.1% by 2019, with more than 88% qualifying as opportunity entrepreneurs. The Federal Reserve’s Survey of Consumer Finances places median net worth for households headed by someone aged 55 to 64 at $364,500, compared to $140,800 for households headed by someone aged 35 to 44. The income and asset profile is not the barrier to coverage.
The health complexity is. The CDC’s National Health Interview Survey shows 72% of adults aged 55 to 64 have at least one chronic condition, compared to 44% of adults aged 35 to 44. Peterson-KFF Health System Tracker analysis of 2023 MEPS data found that people aged 55 and over accounted for 57% of total health spending despite representing only 30% of the population. Milliman’s health cost guidelines place this cohort at 1.8 to 2.2 times the per-capita cost of the 25-to-34 baseline. Pharmaceutical pipelines concentrated in this age band are intensifying the trajectory: PCSK9 inhibitors carry annual costs of approximately $5,000 to $6,000 after manufacturer discounts, and the Alzheimer’s therapies lecanemab (Leqembi, approved 2023) and donanemab (Kisunla, approved 2024) exceed $26,000 per patient annually before infusion and monitoring.
Each available coverage option fails this cohort in a specific, identifiable way. Unsubsidized ACA marketplace premiums for a 60-year-old routinely reach $1,100 to $1,500 per month in metropolitan markets; enhanced subsidies phase out well below the income range this cohort typically occupies. COBRA provides continuity for 18 months at full premium cost and then expires. ICHRA passes the individual-market premium problem to the employee rather than solving it for the owner. Level funded requires 10 or more enrolled lives at standard stop loss terms from carriers such as Sun Life, HM Insurance Group, Tokio Marine HCC, and Voya — a threshold most businesses this cohort forms do not reach in their first three to five years. The BLS Current Population Survey counted approximately 4.3 million self-employed workers aged 55 to 64 in 2023. A substantial share have no adequate group coverage pathway.
A TPA designing a product for the 1-to-50 market must either solve the below-10-lives problem for high-age, high-cost groups or explicitly acknowledge that this cohort sits outside the viable market. Leaving that gap unaddressed is itself a design choice with consequences for Series 15 and Series 16.